Published in Nature on September 02, 1993
Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest (1998) 4.78
Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A (2007) 4.05
Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest (1999) 2.50
Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus. PLoS Pathog (2007) 1.56
Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet (1998) 1.54
Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc Natl Acad Sci U S A (1998) 1.53
Genetic determinants of hepatic steatosis in man. J Lipid Res (2011) 1.52
Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia. Am J Hum Genet (1995) 1.47
Multiple functions of microsomal triglyceride transfer protein. Nutr Metab (Lond) (2012) 1.47
Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function. Circ Cardiovasc Genet (2015) 1.39
Autosomal recessive cerebellar ataxias. Orphanet J Rare Dis (2006) 1.34
Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability. Proc Natl Acad Sci U S A (1994) 1.22
An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc Natl Acad Sci U S A (1996) 1.22
apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes. J Clin Invest (1995) 1.22
Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes. J Clin Invest (1997) 1.20
Pharmacological strategies for lowering LDL cholesterol: statins and beyond. Nat Rev Cardiol (2011) 1.20
Abetalipoproteinemia: two case reports and literature review. Orphanet J Rare Dis (2008) 1.20
Assembly of lipoprotein particles containing apolipoprotein-B: structural model for the nascent lipoprotein particle. Biophys J (2005) 1.00
Defining lipid-interacting domains in the N-terminal region of apolipoprotein B. Biochemistry (2006) 0.99
A distal effect of microsomal triglyceride transfer protein deficiency on the lysosomal recycling of CD1d. J Exp Med (2007) 0.97
Temporal ChIP-on-Chip of RNA-Polymerase-II to detect novel gene activation events during photoreceptor maturation. Mol Vis (2010) 0.93
Origin of hepatic very-low-density lipoprotein triacylglycerol: the contribution of cellular phospholipid. Biochem J (1996) 0.92
Murine mammary-derived cells secrete the N-terminal 41% of human apolipoprotein B on high density lipoprotein-sized lipoproteins containing a triacylglycerol-rich core. Proc Natl Acad Sci U S A (1995) 0.91
Reconstituting initial events during the assembly of apolipoprotein B-containing lipoproteins in a cell-free system. J Mol Biol (2008) 0.91
The role of protein disulphide isomerase in the microsomal triacylglycerol transfer protein does not reside in its isomerase activity. Biochem J (1996) 0.89
Common and rare gene variants affecting plasma LDL cholesterol. Clin Biochem Rev (2008) 0.89
Molecular and functional analysis of two new MTTP gene mutations in an atypical case of abetalipoproteinemia. J Lipid Res (2012) 0.87
Familial hypercholesterolemia: present and future management. Curr Cardiol Rep (2011) 0.86
Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers. Orphanet J Rare Dis (2010) 0.84
Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients. World J Gastroenterol (2008) 0.84
Clinical utility gene card for: Abetalipoproteinaemia. Eur J Hum Genet (2012) 0.83
Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes. Histochem Cell Biol (2007) 0.83
Identification of two novel mutations and long-term follow-up in abetalipoproteinemia: a report of four cases. Eur J Pediatr (2008) 0.83
Clinical Implications of Lipid Genetics for Cardiovascular Disease. Curr Cardiovasc Risk Rep (2010) 0.81
Loss of both phospholipid and triglyceride transfer activities of microsomal triglyceride transfer protein in abetalipoproteinemia. J Lipid Res (2013) 0.81
Insights from human congenital disorders of intestinal lipid metabolism. J Lipid Res (2014) 0.81
Molecular basis of a null mutation in soybean lipoxygenase 2: substitution of glutamine for an iron-ligand histidine. Proc Natl Acad Sci U S A (1994) 0.80
The developing chicken yolk sac acquires nutrient transport competence by an orchestrated differentiation process of its endodermal epithelial cells. J Biol Chem (2012) 0.80
Cholesterol absorption status and fasting plasma cholesterol are modulated by the microsomal triacylglycerol transfer protein -493 G/T polymorphism and the usual diet in women. Genes Nutr (2010) 0.79
Microsomal triglyceride transfer protein activity remains unchanged in rat livers under conditions of altered very-low-density lipoprotein secretion. Biochem J (1995) 0.79
An atypical case of abetalipoproteinaemia with severe fatty liver in the absence of steatorrhoea or acanthocytosis. Eur J Pediatr (2005) 0.79
New Era of Lipid-Lowering Drugs. Pharmacol Rev (2016) 0.77
Corticosterone regulation of ovarian follicular development is dependent on the energy status of laying hens. J Lipid Res (2013) 0.77
Clinical utility gene card for: Abetalipoproteinaemia--Update 2014. Eur J Hum Genet (2014) 0.77
Isolation and complete covalent structure of liver microsomal paraoxonase. Biochem J (1999) 0.77
Baculovirus expression and biochemical characterization of the human microsomal triglyceride transfer protein. Biochem J (1999) 0.77
Vitamin E deficiency begins within 6 months after gastrectomy for gastric cancer. World J Surg (2014) 0.76
Diagnosis of inherited metabolic disorders affecting the nervous system. J Neurol Neurosurg Psychiatry (1995) 0.75
Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategies. Clin Lipidol (2010) 0.75
Systematic review of autosomal recessive ataxias and proposal for a classification. Cerebellum Ataxias (2017) 0.75
Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease. Sci Rep (2017) 0.75
Inhibition of hepatic microsomal triglyceride transfer protein - a novel therapeutic option for treatment of homozygous familial hypercholesterolemia. Vasc Health Risk Manag (2014) 0.75
Closing the circadian loop: CLOCK-induced transcription of its own inhibitors per and tim. Science (1998) 5.72
A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. Science (1991) 5.71
ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell (1992) 5.53
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature (1993) 5.31
Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell (1992) 5.09
Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science (1997) 4.99
The cryb mutation identifies cryptochrome as a circadian photoreceptor in Drosophila. Cell (1998) 4.81
Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol Cell Biol (2000) 4.12
Net1, a Sir2-associated nucleolar protein required for rDNA silencing and nucleolar integrity. Cell (1999) 3.98
A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev (1997) 3.88
A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature (1992) 3.71
Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc (1999) 3.32
Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet (1994) 3.22
A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. Mol Cell Biol (1991) 3.20
Light-induced degradation of TIMELESS and entrainment of the Drosophila circadian clock. Science (1996) 3.11
hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Mol Cell Biol (1999) 3.06
Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation (1999) 2.84
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med (1995) 2.65
BLNK: a central linker protein in B cell activation. Immunity (1998) 2.59
A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet (1999) 2.56
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest (1999) 2.54
Immunolocalization of the mercurial-insensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. Proc Natl Acad Sci U S A (1995) 2.37
Positional cloning and sequence analysis of the Drosophila clock gene, timeless. Science (1995) 2.28
Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science (1992) 2.24
Folding and trimerization of clathrin subunits at the triskelion hub. Cell (1992) 2.23
Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells. J Biol Chem (1995) 2.22
Members of the NAP/SET family of proteins interact specifically with B-type cyclins. J Cell Biol (1995) 2.09
Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity (1996) 2.07
Protein disulfide isomerase is a component of the microsomal triglyceride transfer protein complex. J Biol Chem (1990) 2.06
The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest (2001) 2.04
Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol (2000) 2.02
Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. Science (1998) 2.01
Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases. J Biol Chem (1997) 2.00
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med (1998) 1.98
An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science (1998) 1.93
Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem (1992) 1.88
Purification, identification, and characterization of an osmotic response element binding protein. Biochem Biophys Res Commun (2000) 1.84
Cloning and functional characterization of early B-cell factor, a regulator of lymphocyte-specific gene expression. Genes Dev (1993) 1.84
Identification and sequence of a fourth human T cell antigen receptor chain. Nature (1988) 1.81
Apolipoprotein J: structure and tissue distribution. Biochemistry (1990) 1.73
PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science (1995) 1.68
The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. J Clin Invest (1997) 1.67
Protein disulfide isomerase appears necessary to maintain the catalytically active structure of the microsomal triglyceride transfer protein. Biochemistry (1991) 1.64
Isolation of a ribonucleoprotein complex involved in mRNA localization in Drosophila oocytes. J Cell Biol (2000) 1.63
Possible new type of oral-facial-digital syndrome with retinal abnormalities: OFDS type (VIII) Am J Med Genet (1992) 1.60
Identification of Tyr-397 as the primary site of tyrosine phosphorylation and pp60src association in the focal adhesion kinase, pp125FAK. Mol Cell Biol (1995) 1.60
MDR and PRP: a comparison of methods for high-order genotype-phenotype associations. Hum Hered (2004) 1.59
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry (1994) 1.46
Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation (2001) 1.46
Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I. J Biol Chem (2000) 1.45
Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specific expression and response to metabolic regulators. J Biol Chem (1994) 1.44
Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer. Nature (1986) 1.44
Membrane Ig cross-linking regulates phosphatidylinositol 3-kinase in B lymphocytes. J Immunol (1992) 1.43
Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature (1994) 1.43
Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol (2000) 1.43
Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res (1999) 1.40
A role for the actin-bundling protein L-plastin in the regulation of leukocyte integrin function. Proc Natl Acad Sci U S A (1998) 1.39
Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood (1991) 1.37
Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med (1994) 1.36
Soluble lactose-binding lectin from rat intestine with two different carbohydrate-binding domains in the same peptide chain. J Biol Chem (1993) 1.36
Expression of human adenosine deaminase in murine hematopoietic cells. Mol Cell Biol (1988) 1.35
Mixed modelling to characterize genotype-phenotype associations. Stat Med (2005) 1.31
T cell and antibody reactivity with the Borrelia burgdorferi 60-kDa heat shock protein in Lyme arthritis. J Immunol (1991) 1.29
Identification and cloning of centaurin-alpha. A novel phosphatidylinositol 3,4,5-trisphosphate-binding protein from rat brain. J Biol Chem (1996) 1.28
Gelsolin binding and cellular presentation of lysophosphatidic acid. J Biol Chem (2000) 1.24
Determinants of thrombin receptor cleavage. Receptor domains involved, specificity, and role of the P3 aspartate. J Biol Chem (1995) 1.24
Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem (2001) 1.23
An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc Natl Acad Sci U S A (1996) 1.22
Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease. J Immunol (1992) 1.20
Construction of a defective retrovirus containing the human hypoxanthine phosphoribosyltransferase cDNA and its expression in cultured cells and mouse bone marrow. Mol Cell Biol (1987) 1.17
Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope. J Exp Med (1999) 1.17
Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (1999) 1.16
PKCbeta modulates antigen receptor signaling via regulation of Btk membrane localization. EMBO J (2001) 1.15
Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J Biol Chem (2001) 1.13
Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. J Immunol (1993) 1.13
Purification and characterization of apolipoprotein J. J Biol Chem (1990) 1.12
Impaired Th2 subset development in the absence of CD4. Immunity (1997) 1.12
Mechanisms of thrombin receptor agonist specificity. Chimeric receptors and complementary mutations identify an agonist recognition site. J Biol Chem (1995) 1.11
GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene (1995) 1.11
Inflammatory markers of coronary risk. N Engl J Med (2000) 1.10
Presence of a member of the mitochondrial carrier family in hydrogenosomes: conservation of membrane-targeting pathways between hydrogenosomes and mitochondria. Mol Cell Biol (2000) 1.10
A potential role for Elf-1 in terminal transferase gene regulation. Mol Cell Biol (1996) 1.10
Analgesic effect of watching TV during venipuncture. Arch Dis Child (2006) 1.08
Isolation of a murine gene encoding a nucleic acid-binding protein with homology to hnRNP K. Nucleic Acids Res (1993) 1.07
Synthesis and characterization of histidine-phosphorylated peptides. Protein Sci (1997) 1.07
L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. J Biol Chem (1993) 1.07
Mitotic phosphorylation of the dynein light intermediate chain is mediated by cdc2 kinase. Traffic (2000) 1.06
Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem (1995) 1.06
Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann Surg (1996) 1.06
Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor. Mol Ther (2000) 1.05
Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem Biophys Res Commun (1987) 1.05
The type II transforming growth factor-beta receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem (1997) 1.05
Reconstitution of membrane transport powered by a novel dimeric kinesin motor of the Unc104/KIF1A family purified from Dictyostelium. J Cell Biol (1999) 1.05
Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice. J Lipid Res (2000) 1.05
Control of Leishmania major by a monoclonal alpha beta T cell repertoire. J Immunol (1998) 1.03
Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest (1993) 1.03
Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop. Circulation (2001) 1.03
ABC1: connecting yellow tonsils, neuropathy, and very low HDL. J Clin Invest (1999) 1.03